Trial Profile
A retrospective evaluation of improvements in ICU outcomes in influenza patients treated with high dose oseltamivir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 20 Aug 2015 New trial record